Asco 2015 – Phase I study of combination vemurafenib, carboplatin, and

This topic has 0 replies, 1 voice, and was last updated 9 years, 2 months ago by gavin.

Viewing 1 post (of 1 total)

Author

Posts
May 13, 2015 at 9:31 pm #11239

gavin
Moderator

Phase I study of combination vemurafenib, carboplatin, and paclitaxel in patients (pts) with BRAF-mutant advanced cancer.

http://abstracts.asco.org/156/AbstView_156_148411.html
Author

Posts

Viewing 1 post (of 1 total)

The forum ‘Chemotherapy & More’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation